PLUS1
63.44
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Genomic Health Inc | GHDX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 63.44 | 20:00:00 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 63.44 | 63.44 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 61.13 | 94.19 | 33.06 | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 63.44 | USD |
Genomic Health Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 2.38B | 37.59M | 23.67M | $ 387.32M | $ 50.85M | 0.67 | 43.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 22.00 | 5.50% |
Genomic Health News
| Date | Time | Source | News Article |
|---|---|---|---|
| 2/13/2020 | 06:03 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) |
| 11/18/2019 | 15:19 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under.. |
| 11/18/2019 | 06:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) |
| 11/13/2019 | 16:28 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) |
| 11/13/2019 | 16:26 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) |
| 11/13/2019 | 16:24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 11/08/2019 | 16:46 | Edgar (US Regulatory) | Current Report Filing (8-k) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GHDX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 1 Year | 70.00 | 71.50 | 62.74 | 65.77 | 748,596 | -6.56 | -9.37% |
| 3 Years | 31.00 | 92.18 | 26.54 | 61.24 | 366,509 | 32.44 | 104.65% |
| 5 Years | 24.26 | 92.18 | 20.05 | 51.69 | 266,290 | 39.18 | 161.5% |
Genomic Health Description
| Genomic Health Inc is a healthcare company. It provides genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer. Genomic offers the tissue-based invasive breast, DCIS, prostate, and colon Oncotype DX tests as clinical laboratory services. The company operates in one business segment, which primarily focuses on the development and global commercialization of genomic-based clinical laboratory services. Genomic derives most of its revenue from the United States. |
